[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337535-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337535-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","landscape-and-saturation-analysis-of-mutations-associated-with-race-in-cancer-genomes-by-clinical-sequencing-abstract-and-methods","Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing - Abstract and Methods","","Differences in cancer genomes across racial groups may shape tumor biology and contribute to health disparities, yet prior genomic work has been limited by small and uneven racial representation. This study analyzes race effects on mutation frequency using the GENIE clinical sequencing database with matched-cohort approaches across histologies. Findings include race-specific TERT promoter changes and altered mutation patterns in DNA repair and SWI/SNF chromatin pathway genes, with implications for actionable oncogene targeting. Down-sampling suggests larger samples reveal more race-associated mutations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/landscape-and-saturation-analysis-of-mutations-associated-with-race-in-cancer-genomes-by-clinical-sequencing-abstract-and-methods/337535/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/landscape-and-saturation-analysis-of-mutations-associated-with-race-in-cancer-genomes-by-clinical-sequencing-abstract-and-methods/337535.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is identifying race-associated mutations in cancer genomics difficult in prior studies?","Question",{"text":63,"@type":64},"Prior studies have constrained discovery because Asian and Black patients are underrepresented and sample sizes are limited, reducing statistical power to detect race-associated variants.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which database and strategy were used to evaluate how race affects mutation frequency?",{"text":68,"@type":64},"The GENIE (Genomics, Evidence, Neoplasia, Information, Exchange) database was used, and matched-cohort analyses assessed histology-specific race-associated mutations.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find regarding actionable oncogene mutations and potential therapy impact?",{"text":72,"@type":64},"The distribution of actionable oncogene mutations was race-specific, indicating that targeted therapies may have different impacts across racial groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337535,1790804390,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing  \nMaishara Muquith1, David Hsiehchen*,2  \n1University of Texas Southwestern Medical School, Dallas, TX, USA  \n2Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA * Corresponding author: David Hsiehchen, MD, Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Tel: +1 520 609 0073; Email: [gbtwnow@gmail.com](gbtwnow@gmail.com)  \nAbstract  \nDifferences in cancer genomes between racial groups may impact tumor biology and health disparities. However, the discovery of raceassociated mutations is constrained by the limited representation and sample size of different racial groups in prior genomic studies. We evaluated the influence of race on the frequency of gene mutations using the Genomics, Evidence, Neoplasia, Information, Exchange database, a large genomic dataset aggregated from clinical sequencing. Matched cohort analyses were used to identify histology-specific race-associated mutations including increased TERT promoter mutations in Black and Asian patients with gliomas and bladder cancers, and a decreased frequency of mutations in DNA repair pathway genes and subunits of the SWI/SNF chromatin complex in Asian and Black patients across multiple cancer types. The distribution of actionable mutations in oncogenes was also race-specific, demonstrating how targeted therapies may have a disparate impact on racial groups. Down-sampling analyses indicate that larger sample sizes are likely to discover more race-associated mutations. These results provide a resource to understand differences in cancer genomes between racial groups which may inform the design of clinical studies and patient recruitment strategies in biomarker trials.  \nKey words: cancer genomes; disparities in cancer care; GENIE.  \nImplications for Practice  \nCharacterizing genetic differences in cancers between racial groups may enhance precision medicine by identifying biological factors that impact treatment outcomes and clarifying the genetic basis of cancer disparities to inform public health strategies, clinical guidelines, and policies to reduce inequities. Herein, we leveraged the largest cancer genome databases to evaluate the impact of race on the frequency of gene mutations in cancers. We identified numerous genes more frequently mutated in a racial group across many cancer histologiesand distinct distributions of hotspot mutations in common oncogenes. In addition, down-sampling analyses showed that larger sample sizes are likely to discover more race-associated mutations. Our analysis provides a resource to better understand the genetic contribution to cancer disparities with implications for drug discovery efforts and understanding the relevance of precision oncology to all patients.  \nIntroduction  \nThe incidence and outcomes of multiple cancer types are robustly associated with race.1-5 This has been linked to socioeconomic barriers, behavioral factors, financial limitations, concurrent illness, access to care, treatment disparities, and other inequities within healthcare systems.1-10 However, disparate outcomes between races still persist even within cohorts of cancer patients in randomized trials where baseline characteristics and treatment procedures are more uniform.11-13 Although, other variables contributing to racial disparities in cancer disease burden likely remain to be identified, biological differences in cancers between racial groups may be important determinants of cancer incidence and outcomes after treatment. Genome profiling studies in individual cancer types have demonstrated differences in cancer genomes  \nin various cancers including lung, breast, prostate, gastric, endometrial, and colon cancers.14-24 Moreover, the distribution of tumor mutation burden, a","cbCaibz7aagy42ZM","https://ap.wps.com/l/cbCaibz7aagy42ZM","pdf",18734331,"English","# Abstract\n# Implications for Practice\n# Introduction\n# Methods\n## GENIE Cohort","[{\"question\":\"Why is identifying race-associated mutations in cancer genomics difficult in prior studies?\",\"answer\":\"Prior studies have constrained discovery because Asian and Black patients are underrepresented and sample sizes are limited, reducing statistical power to detect race-associated variants.\"},{\"question\":\"Which database and strategy were used to evaluate how race affects mutation frequency?\",\"answer\":\"The GENIE (Genomics, Evidence, Neoplasia, Information, Exchange) database was used, and matched-cohort analyses assessed histology-specific race-associated mutations.\"},{\"question\":\"What did the study find regarding actionable oncogene mutations and potential therapy impact?\",\"answer\":\"The distribution of actionable oncogene mutations was race-specific, indicating that targeted therapies may have different impacts across racial groups.\"}]","Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing - Abstract and Methods | PDF",1790019541,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b122909ca71b32a361f586b55c48826.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e958044785164a50b0c365597343ede9.webp",982,1290,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1027c5d3d9f9401c39702dd586b107f.webp",981,1289,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/749676adda22d37e71dbe68798cb4375.webp",980,1287]